Search results for "Highlights"


 
Results 211 - 220 of about 228 for "Highlights".
Sort by: Relevance | Newest | Oldest

ACIP revises recommendations on hepatitis A vaccination

For postexposure prophylaxis, the hepatitis A vaccine is now preferred to immune globulin for all adults, including those older than 40 years of age, the Advisory Committee on Immunization Practices (ACIP) said.
https://gastroenterology.acponline.org/archives/2018/11/27/1.htm
27 Nov 2018

Patients may not always want to stop low-value colorectal cancer screening

Veterans at one health system were asked to rate the reasonableness of using age and risk calculators in decisions about screening cessation.
https://gastroenterology.acponline.org/archives/2018/12/28/1.htm
28 Dec 2018

Patients with stable Barrett's esophagus may need less surveillance, study finds

The results could influence the number of endoscopies performed or extend the time between them, the authors noted.
https://gastroenterology.acponline.org/archives/2018/09/28/1.htm
28 Sep 2018

Insufficient evidence to support gluten-free diet for IBS, meta-analysis finds

Included trials evaluated an exclusion diet versus an alternative or usual diet and assessed improvement in either global symptoms of irritable bowel syndrome (IBS) or abdominal pain.
https://gastroenterology.acponline.org/archives/2018/08/24/1.htm
24 Aug 2018

Spotlight on nonalcoholic fatty liver disease and cardiac risk

Studies published in August examined the association between nonalcoholic steatohepatitis and heart failure and the effect of alcohol on cardiovascular risk in patients with nonalcoholic fatty liver disease.
https://gastroenterology.acponline.org/archives/2017/08/25/5.htm
25 Aug 2017

ACP Gastroenterology Monthly introduces editorial advisory board

ACP Gastroenterology Monthly is pleased to introduce its editorial advisory board.
https://gastroenterology.acponline.org/archives/2017/03/24/4.htm
24 Mar 2017

Tofacitinib more effective than placebo for ulcerative colitis, industry-funded study finds

The drug was evaluated in three multicenter, phase 3, randomized, double-blind, placebo-controlled trials involving patients with moderately to severely active disease.
https://gastroenterology.acponline.org/archives/2017/05/26/2.htm
26 May 2017

Anticoagulants safe, effective in cirrhosis with portal vein thrombosis, review finds

Researchers analyzed eight studies with 353 patients to assess the effect of low-molecular-weight heparin or warfarin on recanalization, thrombosis progression, and bleeding.
https://gastroenterology.acponline.org/archives/2017/05/26/3.htm
26 May 2017

8 weeks of ledipasvir/sofosbuvir may be effective for genotype 1 hepatitis C

The therapy should be considered in patients with genotype 1 infection who are treatment-naive, do not have cirrhosis, and have a pretreatment viral load below 6,000,000 IU/mL, a study found.
https://gastroenterology.acponline.org/archives/2017/03/24/2.htm
24 Mar 2017

GI safety profile varies among direct oral anticoagulants

Three propensity-matched cohorts of patients with nonvalvular atrial fibrillation who had incident exposure to dabigatran, rivaroxaban, or apixaban were compared.
https://gastroenterology.acponline.org/archives/2017/01/27/2.htm
27 Jan 2017

Result Page: Prev   17   18   19   20   21   22   23   Next